Li, Mengting
Younis, Muhsin H.
Zhang, Yongxue
Cai, Weibo
Lan, Xiaoli https://orcid.org/0000-0002-7263-7399
Funding for this research was provided by:
National Natural Science Foundation of China (81630049, 82030052)
National Institutes of Health (P30CA014520)
Article History
Received: 25 November 2021
Accepted: 23 January 2022
First Online: 31 January 2022
Change Date: 6 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00259-022-05823-8
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Weibo Cai is a scientific advisor, stockholder, and grantee of Focus-X Therapeutics, Inc. All other authors declare no conflict of interest.